These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36308946)

  • 1. Advanced simulations and screening to repurposing a 3C protease inhibitor against the rupintrivir-resistant human norovirus-induced gastroenteritis.
    Behmard E; Ghasemian A; Barzegari E; Farjadfar A; Kouhpayeh A; Najafipour S
    J Mol Graph Model; 2023 Jan; 118():108345. PubMed ID: 36308946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells
    Kitano M; Hosmillo M; Emmott E; Lu J; Goodfellow I
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
    Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
    J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo.
    Van Dycke J; Dai W; Stylianidou Z; Li J; Cuvry A; Roux E; Li B; Rymenants J; Bervoets L; de Witte P; Liu H; Neyts J; Rocha-Pereira J
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon.
    Rocha-Pereira J; Nascimento MS; Ma Q; Hilgenfeld R; Neyts J; Jochmans D
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4675-81. PubMed ID: 24890597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Gaussia luciferase-based human norovirus protease reporter system: cell type-specific profile of Norwalk virus protease precursors and evaluation of inhibitors.
    Qu L; Vongpunsawad S; Atmar RL; Prasad BV; Estes MK
    J Virol; 2014 Sep; 88(18):10312-26. PubMed ID: 25008934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor.
    Hussey RJ; Coates L; Gill RS; Erskine PT; Coker SF; Mitchell E; Cooper JB; Wood S; Broadbridge R; Clarke IN; Lambden PR; Shoolingin-Jordan PM
    Biochemistry; 2011 Jan; 50(2):240-9. PubMed ID: 21128685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Potential Inhibitors for RNA-Dependent RNA Polymerase of Norovirus: Virtual Screening, and Molecular Dynamics.
    Ebenezer O; Jordaan MA; Damoyi N; Shapi M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir.
    Lacroix C; George S; Leyssen P; Hilgenfeld R; Neyts J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5814-8. PubMed ID: 26055377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
    Binford SL; Weady PT; Maldonado F; Brothers MA; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4366-73. PubMed ID: 17908951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norovirus Protease Structure and Antivirals Development.
    Zhao B; Hu L; Song Y; Patil K; Ramani S; Atmar RL; Estes MK; Prasad BVV
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies.
    Galasiti Kankanamalage AC; Kim Y; Weerawarna PM; Uy RA; Damalanka VC; Mandadapu SR; Alliston KR; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    J Med Chem; 2015 Apr; 58(7):3144-55. PubMed ID: 25761614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
    Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
    J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
    Lockbaum GJ; Henes M; Lee JM; Timm J; Nalivaika EA; Thompson PR; Kurt Yilmaz N; Schiffer CA
    Biochemistry; 2021 Oct; 60(39):2925-2931. PubMed ID: 34506130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404.
    Fàbrega-Ferrer M; Herrera-Morandé A; Muriel-Goñi S; Pérez-Saavedra J; Bueno P; Castro V; Garaigorta U; Gastaminza P; Coll M
    Antiviral Res; 2022 Dec; 208():105458. PubMed ID: 36336176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection.
    Zhang XN; Song ZG; Jiang T; Shi BS; Hu YW; Yuan ZH
    World J Gastroenterol; 2010 Jan; 16(2):201-9. PubMed ID: 20066739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
    Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors.
    Mandadapu SR; Gunnam MR; Tiew KC; Uy RA; Prior AM; Alliston KR; Hua DH; Kim Y; Chang KO; Groutas WC
    Bioorg Med Chem Lett; 2013 Jan; 23(1):62-5. PubMed ID: 23218713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current tools for norovirus drug discovery.
    Weerasekara S; Prior AM; Hua DH
    Expert Opin Drug Discov; 2016 Jun; 11(6):529-41. PubMed ID: 27108716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.